Cargando…

Systems Biology Integrative Biology and Simulation Tools /

Growth in the pharmaceutical market has slowed down - almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Prokop, Aleš (Editor ), Csukás, Béla (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Dordrecht : Springer Netherlands : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-94-007-6803-1
003 DE-He213
005 20220118174311.0
007 cr nn 008mamaa
008 130828s2013 ne | s |||| 0|eng d
020 |a 9789400768031  |9 978-94-007-6803-1 
024 7 |a 10.1007/978-94-007-6803-1  |2 doi 
050 4 |a R850.A1-854 
050 4 |a QH315-320 
072 7 |a MBGR  |2 bicssc 
072 7 |a MED000000  |2 bisacsh 
072 7 |a MBGR  |2 thema 
082 0 4 |a 610.72  |2 23 
245 1 0 |a Systems Biology  |h [electronic resource] :  |b Integrative Biology and Simulation Tools /  |c edited by Aleš Prokop, Béla Csukás. 
250 |a 1st ed. 2013. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2013. 
300 |a XXXI, 553 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Functional genomics, proteomics, metabolomics and bioinformatics for systems biology -- Comparing biological networks: a survey on graph classifying techniques -- Emergent properties of gene regulatory networks - models and data -- Regulatory crosstalk analysis of biochemical networks in the nucleus accumbens -- Properties of biological networks -- Network analysis for systems biology -- Computational approaches for reconstruction of time-varying biological networks from Omics data -- Probabilistic graphical modeling in systems biology: a framework for integrative approaches -- Innovations of the rule-based modeling approach -- Reproducibility of model-based results in systems biology -- Parameter identifiability and redundancy, with applications to a general class of stochastic carcinogenesis models -- Semantic systems biology: formal knowledge representation in systems biology for model construction, retrieval, validation and discovery -- Computational infrastructures for data and knowledge management in systems biology -- Computational tools and resources for integrative modeling in systems biology -- Agent-based modeling approaches to multi-scale systems biology: An example agent-based model of acute pulmonary inflammation -- Reconstructing cellular signaling and regulatory networks - an integrative approach for systems-level drug discovery -- A survey of current integrative network algorithms for systems biology -- Direct Computer Mapping based modeling of a multiscale process, involving p53/miR-34a signaling. 
520 |a Growth in the pharmaceutical market has slowed down - almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies - the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 0 |a Microbial genetics. 
650 0 |a Computer simulation. 
650 0 |a Biomedical engineering. 
650 1 4 |a Biomedical Research. 
650 2 4 |a Microbial Genetics. 
650 2 4 |a Computer Modelling. 
650 2 4 |a Biomedical Engineering and Bioengineering. 
700 1 |a Prokop, Aleš.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Csukás, Béla.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789400794542 
776 0 8 |i Printed edition:  |z 9789400768024 
776 0 8 |i Printed edition:  |z 9789400768048 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-94-007-6803-1  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)